These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16235351)

  • 1. Antihypertensive agents for preventing diabetic kidney disease.
    Strippoli GF; Craig M; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004136. PubMed ID: 16235351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive agents for preventing diabetic kidney disease.
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive agents for primary prevention of diabetic nephropathy.
    Strippoli GF; Craig M; Schena FP; Craig JC
    J Am Soc Nephrol; 2005 Oct; 16(10):3081-91. PubMed ID: 16135776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.
    Natale P; Palmer SC; Navaneethan SD; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD006257. PubMed ID: 38682786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression.
    Strippoli GF; Craig MC; Schena FP; Craig JC
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S153-5. PubMed ID: 16565242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.
    Vejakama P; Thakkinstian A; Lertrattananon D; Ingsathit A; Ngarmukos C; Attia J
    Diabetologia; 2012 Mar; 55(3):566-78. PubMed ID: 22189484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive treatment for kidney transplant recipients.
    Cross NB; Webster AC; Masson P; O'Connell PJ; Craig JC
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD003598. PubMed ID: 19588343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.
    Strippoli GF; Bonifati C; Craig M; Navaneethan SD; Craig JC
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006257. PubMed ID: 17054288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
    Zhang L; Zeng X; Fu P; Wu HM
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
    Perez MI; Musini VM; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.